Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Our multidisciplinary approach to care ensures Center for Prevention of Progression patients benefit from experts in their condition, genetic counseling, diagnostics, social support, and more.
Our Center offers advanced diagnostic and sequencing technology to diagnose and assess each patient's condition. The information gathered can help determine risk of progression, inform treatment or management, and support research efforts to better understand
Patients meet with a hematologist/oncologist with an in-depth knowledge of their condition. The hematologist/oncologist will evaluate options for management or early treatment for each patient.
An experienced genetic counselor discusses a patient's personal and family health history, cancer risk, and potential strategies to lower the risk of progression.
Psychologists and social workers offer patients resources and support as they evaluate and manage their condition.
Patients may be offered the chance to participate in clinical trials. These trials may include tissue banking studies such as PCROWD, or therapy trials evaluating the effectiveness
of treatments in preventing disease progression.
Some patients with CHIP may need evaluation by specialists such as cardiologists to try to assess and reduce risk of cardiovascular events.
Center for Prevention of Progression Appointments